The Alzheimer’s Research UK Conference has an exciting line up of speakers covering a wide range of topics.
| 9:30 – 10:00 | Welcomes |
| 10:00 – 11:00 | Process of drug discovery and design - basic to translational research |
| Dr Mike O'Neill (Abbvie): Disease Modifying Drug Discovery Approaches for Alzheimer’s Disease | |
| Dr John Davis (The Oxford Drug Discovery Institute): Steps for de-risking drug discovery projects | |
| Dr Diego Gomez-Nicola (University of Southampton): Understanding and targeting neuroinflammation in Alzheimer's disease | |
| Dr Emily Baker (Cardiff University): To what extent can microglia, synapse and lipid genes be used to inform drug discovery | |
| 11:00 – 11:15 | Break |
| 11:15 – 11:45 | Prizes |
| David Hague Young Investigator of the Year award | |
| Jean Corsan Prize Winner | |
| 11:45 – 12:30 | Posters and networking |
| 9:30 – 10:15 | Novel therapies and clinical implications |
| Dr Francesco Antonio Aprile (Imperial College London): Antibody discovery for neurodegeneration | |
| Prof Anne Rosser (Cardiff University): Novel therapies for Huntington's Disease: how did we get here and what is the way ahead? | |
| Dr Lucy Beishon (University of Leicester): The Effects of Brain Training on Brain Blood Flow: Results from the Cognition and Flow Study (CoGFlowS) | |
| 10:15 – 10:30 | Break |
| 10:30 – 11:15 | Panel discussion – clinical trials |
| Dr Ben Underwood (University of Cambridge) | |
| Dr Vanessa Raymont (University of Oxford) | |
| Dr Chris Kalafatis | |
| Prof Craig Ritchie | |
| 11:15 – 11:30 | Break |
| 11:30 – 13:00 | Early detection of neurodegenerative diseases |
| Zoe Kourtzi (intro) | |
| Dennis Chan | |
| Chris Hinds | |
| Zuzana Walker | |
| Prof Richard Everson | |
| 13:00 – 13:30 | Lunch |
| 13:30 – 14:15 | Posters and networking |
| 12:30 – 13:30 | Viral infection and dementia |
| Prof Clayton A Wiley (University of Pittsburgh): Viral infection and dementia: A brief synthesis | |
| Associate Prof Colm Cunningham (Trinity College Dublin): Systemic anti-viral responses drive brain interferon and neuroinflammatory activation and can drive progression of neurodegenerative disease | |
| Prof Markus Glatzel (University Medical Center Hamburg-Eppendor): (How) does SARS-CoV-2 damage the brain? | |
| Dr Dervis Salih (University College London): An expression quantitative trait locus associated with oligoadenylate synthetase 1, OAS1, in myeloid cells increases the risk of Alzheimer’s disease and severe Covid-19 outcomes | |
| 13:30 – 13:45 | Break |
| 13:45 – 14:45 | Biomarkers |
| Prof Nick Fox (University College London): Imaging and biomarkers – from diagnosis to trials – changing roles and recent results | |
| Prof Henrik Zetterberg (University of Gothenburg/University College London): Fluid biomarkers for neurodegenerative dementias - from CSF to blood | |
| Dr Petroula Proitsi (King's College London): Deciphering the role of blood metabolites in Alzheimer’s Disease | |
| Dr Maria Paraskevaidi (University of Central Lancashire): The use of spectroscopic techniques for the non-invasive diagnosis of Alzheimer’s disease | |
| 14:45 – 15:30 | Posters and networking |
| 12:30 – 13:30 | Other dementia/tauopathies |
| Dr Javier Alegre-abarrategui (Imperial College London): Visualisation in situ of early aggregation in neurodegeneration | |
| Dr Pete Nelson (University of Kentucky): Pathologic and clinical variability in LATE: focus on quadruple-misfolded proteinopathy | |
| Prof Selina Wray (University College London): Investigating tau proteostasis in development and disease using induced pluripotent stem cells | |
| Dr Rachel Waller (The University of Sheffield): What happens to cells of the brain in people who develop dementia after stroke? | |
| 13:30 – 13:45 | Break |
| 13:45 – 14:45 | Neurosensory aspect of Dementia |
| Dr Maya Koronyo-Hamaoui (Cedars-Sinai Medical Center): Retinal vasculopathy in Alzheimer’s disease: predicting disease status | |
| Prof Jason Warren (University College London): Hearing and Alzheimer’s disease: from ears to brain | |
| Prof Paul Morgan (Cardiff University): Complement as a driver of inflammation in Alzheimer's disease | |
| Miss Karina Vitanova (University College London): Alterations in synaptic transmission at plaque-associated axons in APP knock-in models of Alzheimer's Disease | |
| 14:45 – 14:55 | Prize presentation |
| Laura Pulford Prize | |
| The Iceland Foods Charitable Foundation Communications Prize | |
| The Sir Malcolm Walker Award and The Lady Walker Award |
